<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/935B2919-2093-4FB9-A5D4-59F746D5235A"><gtr:id>935B2919-2093-4FB9-A5D4-59F746D5235A</gtr:id><gtr:name>University of California, Irvine</gtr:name><gtr:address><gtr:line1>UCI</gtr:line1><gtr:postCode>92697</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9218106A-E8CE-46A5-AABC-B4C8ED148690"><gtr:id>9218106A-E8CE-46A5-AABC-B4C8ED148690</gtr:id><gtr:name>University of Amsterdam</gtr:name><gtr:address><gtr:line1>Liaison Office</gtr:line1><gtr:line2>PO Box 19268</gtr:line2><gtr:line4>Amsterdam</gtr:line4><gtr:line5>Amsterdam</gtr:line5><gtr:postCode>1000 GG</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Child Health</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/935B2919-2093-4FB9-A5D4-59F746D5235A"><gtr:id>935B2919-2093-4FB9-A5D4-59F746D5235A</gtr:id><gtr:name>University of California, Irvine</gtr:name><gtr:address><gtr:line1>UCI</gtr:line1><gtr:postCode>92697</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9218106A-E8CE-46A5-AABC-B4C8ED148690"><gtr:id>9218106A-E8CE-46A5-AABC-B4C8ED148690</gtr:id><gtr:name>University of Amsterdam</gtr:name><gtr:address><gtr:line1>Liaison Office</gtr:line1><gtr:line2>PO Box 19268</gtr:line2><gtr:line4>Amsterdam</gtr:line4><gtr:line5>Amsterdam</gtr:line5><gtr:postCode>1000 GG</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/534E81AC-9DCD-4969-9740-980D137F6062"><gtr:id>534E81AC-9DCD-4969-9740-980D137F6062</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Copp</gtr:surname><gtr:orcidId>0000-0002-2544-9117</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BAA12657-4EC0-44F2-8692-7F31391D0C43"><gtr:id>BAA12657-4EC0-44F2-8692-7F31391D0C43</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:surname>Greene</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802163"><gtr:id>A2C000AB-580B-4045-8575-636F45A413E6</gtr:id><gtr:title>Grainyhead-like genes and mammalian neural tube defects</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802163</gtr:grantReference><gtr:abstractText>During early pregnancy, a crucial event in the developing embryo is the formation of the neural tube, which will later develop into the brain and spinal cord. Failure of the neural tube to form correctly leads to a group of birth defects called neural tube defects (NTDs), in which the brain and/or spinal cord of the fetus become irreversibly damaged, resulting in death before or shortly after birth, or handicap in surviving babies. Overall, NTDs occur in around 1 per 1,000 pregnancies although the rate varies and is significantly higher in some regions (e.g. Northern Ireland and Scotland). Worldwide, approximately 130,000 cases occur every year. The risk of NTDs depends on both inherited genetic factors and non-genetic factors such as diet, but the exact causes are not well understood. We are studying mouse strains that are predisposed to develop NTDs that resemble the corresponding human birth defects, with the aim of understanding why the defects develop and finding ways to prevent them. In one of these strains, curly tail, we found that reduced expression of a gene called grainyhead-like-3, causes NTDs. We now have evidence to suggest that increased expression of the same gene or a related gene, grainyhead-like-2, can also cause NTDs, and we propose to use genetic approaches to test this idea. We will then investigate how the altered expression of the grainyhead-like genes changes cellular behaviours and thereby alters the mechanical properties of the developing embryo such that the neural tube fails to close. Finally, we will test whether dysregulation of grainyhead-like-2 and -3 cause NTDs through similar or differing effects on the expression of other ?downstream? genes. Identification of the genes that cause NTDs in mice may indicate genes that may be causative in humans. Knowledge of the genes responsible for NTDs in humans may then allow more accurate counselling for affected families who are considering a further pregnancy, and may allow development of novel therapeutic strategies.</gtr:abstractText><gtr:technicalSummary>Neural tube defects (NTDs), such as spina bifida and anencephaly, are severe congenital malformations caused by failure of closure of the embryonic neural tube. Folic acid supplementation can prevent some NTDs but a significant proportion (at least 30%) are unresponsive, and these defects remain a major health issue in the UK and worldwide. The causes of human NTDs are still largely unknown, but appear to involve multiple genetic and environmental factors. Therefore, our long term aim is to use detailed knowledge of the molecular and developmental basis of the pathogenesis of NTDs in mouse models, to assist identification of genetic risk factors for the corresponding human birth defects and development of primary preventive strategies. Several lines of evidence suggest that spinal neurulation depends on precise regulation of expression of members of the grainyhead-like (Grhl) gene family, and that their dysregulation confers susceptibility to NTDs. We previously found that reduced expression of Grhl3 causes spinal NTDs in curly tail mice, a model for folate-resistant and inositol-responsive NTDs. We now have preliminary data to suggest that over-expression of Grhl3 can also cause spinal NTDs, and that this may involve a distinct mechanism from that in the curly tail model. Furthermore, mapping and expression studies in another partially penetrant model for spinal NTDs, the Axial defects (Axd) mouse, suggest that the causative genetic defect involves a regulatory mutation resulting in over-expression of another Grhl member, Grhl2. We will build on these findings by, (1) testing the hypothesis that Grhl2 over-expression is the direct cause of NTDs in Axd. Suppression of Grhl2 function in Axd mice is predicted to rescue neurulation defects, whereas, transgenic over-expression of Grhl2 in wild-type embryos is predicted to cause NTDs. Next, (2) a series of studies will investigate the cellular and developmental basis of NTDs in Grhl2 and Grhl3 over-expression models, to determine whether the mechanism is shared with, or distinct from, that which we previously found to operate in the curly tail model. We will test whether NTDs caused by over-expression of Grhl3 involve a re-opening defect, which would represent a novel mechanism for development of spinal NTDs. Finally, (3) we will test the idea that over-expression of Grhl2 results in suppression of Grhl3 function, through disruption of transcription factor dimerisation, such that NTDs in the Axd (Grhl2 over-expression) and curly tail (Grhl3 under-expression) models, share a similar molecular basis in terms of aberrant expression of downstream genes.</gtr:technicalSummary><gtr:fund><gtr:end>2013-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>629865</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Lamin B1 Cell Biology</gtr:description><gtr:id>EE6482D3-74A8-4F92-A5B1-B4FDD8F4133E</gtr:id><gtr:impact>This data forms part of a manuscript to be submitted late 2010.</gtr:impact><gtr:outcomeId>ryxxedQmv4G-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators carried out FLIP assay and cell morphometric analysis to test the functional effect of a variant of lamin B1 that we found to affect susceptibility to spina bifida</gtr:partnerContribution><gtr:piContribution>We identified a variant form of lamin B1 in mice that are predisposed to spina bifida. We carried otu genetic experiments that showed that the lamin B1 variant strongly influences risk of spina bifida. We generated constructs and primary cell lines for analysis by our collaborators.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Amsterdam</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Axial Defects mice</gtr:description><gtr:id>847B0732-233F-4253-9FA3-6D8185C01165</gtr:id><gtr:impact>We have identified the causative gene in the Axial Defects mouse model (manuscript submitted).</gtr:impact><gtr:outcomeId>BWbVdUPEo6M-1</gtr:outcomeId><gtr:partnerContribution>Collaborator supplied Axial Defects mutant mouse and shared data on linkage analysis which mapped the causative mutation.</gtr:partnerContribution><gtr:piContribution>We have carried out extensive analysis of the Axial Defects mutant mouse - a model for apisna bifida. This includes gene expression analysis, measurements of cell proliferation, morphological studies and genetic experiments to identify the causative gene.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Karolinska - Genetics of NTDs</gtr:description><gtr:id>B32193F1-2A4B-4D0B-A24D-DE441BBE31B1</gtr:id><gtr:impact>We showed that reduced expression of grainyhead-like3 is the cause of neural tube defects in the curly tail mouse model. We identified a polymorphism as a modifier of neural tube defects risk in curly tail mice and began analysis in human patients. Publications: 18683893 and 17720888</gtr:impact><gtr:outcomeId>C680BD3EA59-1</gtr:outcomeId><gtr:partnerContribution>Our collaborator has contributed to design and analysis of microarray and transgenic investigations of grainyhead-like mutant mice. In addition Dr Gustavsson has collected patient DNA samples for analysis of candidate genes for neural tube defects.</gtr:partnerContribution><gtr:piContribution>We have been investigating the development and prevention of neural tube defects in grainyhead-like3 mutant mice. These studies have involved generation of novel transgenic mouse strains. Proteomic analysis has identified a modifier gene, which is a candidate to be involved in human neural tube defects.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, Irvine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Grainyhead-like genes</gtr:description><gtr:id>07F9354F-33E1-4703-A45B-12CF3C1F87AF</gtr:id><gtr:impact>Data will contribute to manuscripts currently under preparation.</gtr:impact><gtr:outcomeId>pKPTzfuwEqw-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators provided a conditional knockout mouse strain for Grhl3. They also shared data on conditional knokout in specific tissues.</gtr:partnerContribution><gtr:piContribution>We have performed genetic and cellular analysis of mice carrying conditional targeted mutation of the Grhl3 gene.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BBC Radio - Five Live</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AF323761-70F3-4774-91A1-A52DE5489721</gtr:id><gtr:impact>Live radio interview discussing spina bifida, the need for women to take folic acid and the possibility that additional therapies are required. Resulted in increased awareness of clinical trial for prevention of neural tube defects by inositol - additional women entered trial after hearing radio interview.

Additional media interest in clinical trial. Contact from potantial trial participants and clnicians</gtr:impact><gtr:outcomeId>BibxJSSDgfg</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio Five Live</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F9B7EF0A-AB19-4303-87B4-EF67401A3B55</gtr:id><gtr:impact>Increased public awareness of research into neural tube defects.

Increased entry in clinical trial in progress in our laboratory.</gtr:impact><gtr:outcomeId>ZdBB1kAoL1v</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC News 24, BBC Online, BBC Regional News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F83E15ED-0892-441C-AAE2-E54E9BF3700E</gtr:id><gtr:impact>I was interviewed for a television piece which focussed on spina bifida, its possible prevention by folic acid and the need for additional therapies as folic acid does not prevent all cases. The interview also introduced our current clinical trial.

Increased recruitment into clinical trial.</gtr:impact><gtr:outcomeId>QG2ydyyDhUV</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC TV - Breakfast</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B5DF44E5-478B-49A5-8B81-0BDF874C0E5C</gtr:id><gtr:impact>Live TV interview discussing spina bifida, the need for women to take folic acid and the possibility that additional therapies are required. Resulted in increased awareness of clinical trial for prevention of neural tube defects by inositol - additional women entered trial after seeing TV interview.

Increased public awareness of neural tube defects, the need for folic acid supplementation and the possible benefit of additional therapies, such the as one being tested in the clinical trial run by this resaerch group.</gtr:impact><gtr:outcomeId>KF65TStG9LL</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Careers forum</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EA4431A4-8FC7-41D4-97A4-0D84DD20578E</gtr:id><gtr:impact>80 undergraduate and post-graduate students attended a careers forum, involving talks and a question and answer session about academic careers

Many students reported that their understanding of the pros and cons of academia was clarified</gtr:impact><gtr:outcomeId>gpA9tb6uDTQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>119000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Newlife Project Grant</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Newlife</gtr:fundingOrg><gtr:id>EF4109BD-BE67-4881-A5F3-5DB17BE3EAD0</gtr:id><gtr:outcomeId>ss9AadTS596</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>13259</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Newlife Start-Up Grant</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Newlife</gtr:fundingOrg><gtr:fundingRef>SG/15-16/04</gtr:fundingRef><gtr:id>5F20B88D-7E6E-4AA6-B0CB-489CB04E66E9</gtr:id><gtr:outcomeId>56caf0bd2f68a8.40771002</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>RNA Seq data for Grhl3 and Grhl2 loss and gain of function models</gtr:description><gtr:id>DA84DC08-94CD-4A34-AF9E-9CFE13B0004D</gtr:id><gtr:impact>Imporved understanding of the molecular mechanisms mediated by Grhl gene function.</gtr:impact><gtr:outcomeId>58b6f413e4a302.86134398</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Grhl2 and Grhl3 RNA-Seq datasets</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Data from microarray analysis performed in order to identify genes whose expression is altered in the curly tail mouse model of neural tube defects</gtr:description><gtr:id>F4289F02-2E18-46A1-BCDC-B275B1DBD13D</gtr:id><gtr:impact>Genes whose altered expression may contribute to development of neural tube defects have been identified. These genes are under analysis in functional studies.</gtr:impact><gtr:outcomeId>5459053ce50e41.60567003</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Grhl3 - curly tail microarray</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We developed a novel method for quantification of inositol in biological matrices. This involved a novel HPLC step to separate inositol from other 6 carbon sugars and sugar alcohols.</gtr:description><gtr:id>DE720280-CE16-4AE1-9119-3CF878B07606</gtr:id><gtr:impact>Improvement in accuracy of inositol assays</gtr:impact><gtr:outcomeId>oPZTbFnr1y7</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>LC-MS/MS method - inositol</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A gene-trap line of Grhl2 mice which carry a loss of function allele of Grhl2.</gtr:description><gtr:id>A38E00D9-E0DA-4BE0-8A97-62C540B6B2EA</gtr:id><gtr:impact>We used Grhl2 mutant mice in a complementation experiment to demonstrate that neural tube defects in Axial Defects mutant mice result from over-expression of Grhl2. We found that loss of Grhl2 function causes neural tube defects. These findings indicate Grhl2 as a candidate gene for human NTDs.</gtr:impact><gtr:outcomeId>mFPiU3iNu42</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Grhl2 mutant mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BAF5E659-0F73-4DBB-9EC1-D4B6F77489BA</gtr:id><gtr:title>Regional differences in the expression of laminin isoforms during mouse neural tube development.</gtr:title><gtr:parentPublicationTitle>Matrix biology : journal of the International Society for Matrix Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e4ace1bcd4ed13d992a5c3970c5371"><gtr:id>08e4ace1bcd4ed13d992a5c3970c5371</gtr:id><gtr:otherNames>Copp AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0945-053X</gtr:issn><gtr:outcomeId>pm_12616_26_21524702</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BFBF67D-1DF5-4006-BEBD-E2EC8E4244D6</gtr:id><gtr:title>Lamin b1 polymorphism influences morphology of the nuclear envelope, cell cycle progression, and risk of neural tube defects in mice.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d26ee11f574ee83f0b765efd4a21c283"><gtr:id>d26ee11f574ee83f0b765efd4a21c283</gtr:id><gtr:otherNames>De Castro SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_12616_26_23166514</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6BE4D7F-98EC-4FC3-A03C-CA9BFD4E21E7</gtr:id><gtr:title>Inositol, neural tube closure and the prevention of neural tube defects.</gtr:title><gtr:parentPublicationTitle>Birth defects research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05d5ad6709a1d670da68174acc885ac4"><gtr:id>05d5ad6709a1d670da68174acc885ac4</gtr:id><gtr:otherNames>Greene ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>585d3173a0d8c9.85231237</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>517EA23E-CB4B-4993-9EEB-E70054E60779</gtr:id><gtr:title>Mutations in genes encoding the glycine cleavage system predispose to neural tube defects in mice and humans.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/521fb48b632ee7f4cbceb41ead2ab124"><gtr:id>521fb48b632ee7f4cbceb41ead2ab124</gtr:id><gtr:otherNames>Narisawa A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_12616_26_22171071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1073FA3-ED12-4B3E-B05E-5297759ADF56</gtr:id><gtr:title>Neural tube defects.</gtr:title><gtr:parentPublicationTitle>Annual review of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05d5ad6709a1d670da68174acc885ac4"><gtr:id>05d5ad6709a1d670da68174acc885ac4</gtr:id><gtr:otherNames>Greene ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0147-006X</gtr:issn><gtr:outcomeId>5458f579720da9.68360887</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0865AE7-5336-4B80-A40C-F8E13BEB8E71</gtr:id><gtr:title>Epithelial fusion during neural tube morphogenesis.</gtr:title><gtr:parentPublicationTitle>Birth defects research. Part A, Clinical and molecular teratology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e7b6c4295e6ff006ca4adcda162378e"><gtr:id>5e7b6c4295e6ff006ca4adcda162378e</gtr:id><gtr:otherNames>Pai YJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1542-0752</gtr:issn><gtr:outcomeId>pm_12616_26_22945349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC4C2571-8763-4DAB-A188-CB2CAB248F2A</gtr:id><gtr:title>Bloomsbury report on mouse embryo phenotyping: recommendations from the IMPC workshop on embryonic lethal screening.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41ee338773829acb3c4e72f873e16db3"><gtr:id>41ee338773829acb3c4e72f873e16db3</gtr:id><gtr:otherNames>Adams D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>pm_12616_26_23519032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>649EB588-ABE5-49FB-B2A5-ACDA181D1F52</gtr:id><gtr:title>Protein deiminases: new players in the developmentally regulated loss of neural regenerative ability.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/715f0643516bc319dfd0db35ecb6e957"><gtr:id>715f0643516bc319dfd0db35ecb6e957</gtr:id><gtr:otherNames>Lange S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>pm_12616_26_21539830</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F80475E5-53E6-4A89-B756-93D7F2FBD63A</gtr:id><gtr:title>Genetic interactions between planar cell polarity genes cause diverse neural tube defects in mice.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ef4be539af0f87fd24aa4d6174bf5ce"><gtr:id>5ef4be539af0f87fd24aa4d6174bf5ce</gtr:id><gtr:otherNames>Murdoch JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>doi_55f984984f5e4ee1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4541773A-FA59-4F41-92E7-BB5824CD48D4</gtr:id><gtr:title>Neural tube closure depends on expression of Grainyhead-like 3 in multiple tissues.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ef0c8ec974765e26db57e79a4be9715"><gtr:id>5ef0c8ec974765e26db57e79a4be9715</gtr:id><gtr:otherNames>De Castro SCP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>5a93f06d5b19c5.16828418</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90020D7A-C113-446A-A61E-2A6204627E3D</gtr:id><gtr:title>Claudins are essential for cell shape changes and convergent extension movements during neural tube closure.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37c53123b301264d48ff297d24bf46e1"><gtr:id>37c53123b301264d48ff297d24bf46e1</gtr:id><gtr:otherNames>Baumholtz AI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>5a31df9288d9a9.94724056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A2BC8B9-7D21-475E-9DF8-0F3735A7CB3D</gtr:id><gtr:title>Neural tube defects--disorders of neurulation and related embryonic processes.</gtr:title><gtr:parentPublicationTitle>Wiley interdisciplinary reviews. Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e4ace1bcd4ed13d992a5c3970c5371"><gtr:id>08e4ace1bcd4ed13d992a5c3970c5371</gtr:id><gtr:otherNames>Copp AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1759-7684</gtr:issn><gtr:outcomeId>pm_12616_26_24009034</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C4BDAFD-8A4D-4805-A92A-8B6E3F5CD7BA</gtr:id><gtr:title>Could microRNAs be biomarkers for neural tube defects?</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05d5ad6709a1d670da68174acc885ac4"><gtr:id>05d5ad6709a1d670da68174acc885ac4</gtr:id><gtr:otherNames>Greene ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>pm_12616_26_22631213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A28505BB-2BF9-45C4-A56F-85BB1094CF72</gtr:id><gtr:title>Diffusion microscopic MRI of the mouse embryo: Protocol and practical implementation in the splotch mouse model.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a00df7835064f5c8e459f8775608b485"><gtr:id>a00df7835064f5c8e459f8775608b485</gtr:id><gtr:otherNames>Norris FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>doi_55f95595500bb976</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1236668E-53E6-454C-9AE9-AFA02EF07325</gtr:id><gtr:title>A coming of age: advanced imaging technologies for characterising the developing mouse.</gtr:title><gtr:parentPublicationTitle>Trends in genetics : TIG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a00df7835064f5c8e459f8775608b485"><gtr:id>a00df7835064f5c8e459f8775608b485</gtr:id><gtr:otherNames>Norris FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0168-9525</gtr:issn><gtr:outcomeId>pm_12616_26_24035368</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04A80A64-E96A-4591-BE30-2A61E40413BB</gtr:id><gtr:title>Neural tube defects: recent advances, unsolved questions, and controversies.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e4ace1bcd4ed13d992a5c3970c5371"><gtr:id>08e4ace1bcd4ed13d992a5c3970c5371</gtr:id><gtr:otherNames>Copp AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_12616_26_23790957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED3A94E3-3638-4073-B13C-C10D0CC5A072</gtr:id><gtr:title>Regulation of cell protrusions by small GTPases during fusion of the neural folds.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b4963cde8159afc4eb51cfd5be8c0c4"><gtr:id>1b4963cde8159afc4eb51cfd5be8c0c4</gtr:id><gtr:otherNames>Rolo A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>585d4091af4531.01241969</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEFEBCD4-8120-460D-AAAB-100A136F10C7</gtr:id><gtr:title>Neural tube defects induced by folate deficiency in mutant curly tail (Grhl3) embryos are associated with alteration in folate one-carbon metabolism but are unlikely to result from diminished methylation.</gtr:title><gtr:parentPublicationTitle>Birth defects research. Part A, Clinical and molecular teratology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d26ee11f574ee83f0b765efd4a21c283"><gtr:id>d26ee11f574ee83f0b765efd4a21c283</gtr:id><gtr:otherNames>De Castro SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1542-0752</gtr:issn><gtr:outcomeId>pm_12616_26_20589880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF6A2637-D77A-4E8A-92A9-654C5ECC2674</gtr:id><gtr:title>Is LMNB1 a susceptibility gene for neural tube defects in humans?</gtr:title><gtr:parentPublicationTitle>Birth defects research. Part A, Clinical and molecular teratology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87066f07948e49b685ffb15e30237215"><gtr:id>87066f07948e49b685ffb15e30237215</gtr:id><gtr:otherNames>Robinson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1542-0752</gtr:issn><gtr:outcomeId>pm_12616_26_23733478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BF79199-0628-4FC5-A783-BBD4A87DD2E2</gtr:id><gtr:title>Neural tube closure: cellular, molecular and biomechanical mechanisms.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21cdeb42341d0fae6848ac683160f9c3"><gtr:id>21cdeb42341d0fae6848ac683160f9c3</gtr:id><gtr:otherNames>Nikolopoulou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>58b6fc420dcba0.44406268</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDE01346-642D-4D81-B923-625697ED49E8</gtr:id><gtr:title>Over-expression of Grhl2 causes spina bifida in the Axial defects mutant mouse.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50fc7ae4f7ba894ba8cf825d2214d290"><gtr:id>50fc7ae4f7ba894ba8cf825d2214d290</gtr:id><gtr:otherNames>Brouns MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>95E6A5D2_F95E6A5D2_F</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802163</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>